The lancet. HIV

· 1 paper in corpus
2021
doi:10.1016/s2352-3018(20)30304-0 ·PMID:33539762

BackgroundTwo phase 3 clinical trials showed that use of a monthly vaginal ring containing 25 mg dapivirine was well tolerated and reduced HIV-1 incidence in women by approximately 30% compared with placebo. We aimed to evaluate use and saf…